- Gebundenes Buch
- Merkliste
- Auf die Merkliste
- Bewerten Bewerten
- Teilen
- Produkt teilen
- Produkterinnerung
- Produkterinnerung
The Future of Pharmaceuticals: A Nonlinear Analysis provides an opportunity to understand the non-linearity of biological systems and its application in various areas of science, primarily pharmaceutical sciences. This book will benefit professionals in pharmaceutical industries, academia, and policy.
Andere Kunden interessierten sich auch für
- Ronald P EvensBiotechnology243,99 €
- Howard Bernstein (ed.)Microparticulate Systems for the Delivery of Proteins and Vaccines423,99 €
- Yaser Al-WorafiPatient Safety in Developing Countries211,99 €
- Process Chemistry in the Pharmaceutical Industry, Volume 2423,99 €
- Siavoush DastmalchiQuantitative Structure - Activity Relationship267,99 €
- David B. Weiner / William V. WilliamsChemical and Structural Approaches to Rational Drug Design529,99 €
- Daniel PurichThe Inhibitor Index299,99 €
-
-
-
The Future of Pharmaceuticals: A Nonlinear Analysis provides an opportunity to understand the non-linearity of biological systems and its application in various areas of science, primarily pharmaceutical sciences. This book will benefit professionals in pharmaceutical industries, academia, and policy.
Produktdetails
- Produktdetails
- Verlag: Taylor & Francis Ltd (Sales)
- Seitenzahl: 568
- Erscheinungstermin: 1. März 2022
- Englisch
- Abmessung: 254mm x 178mm x 33mm
- Gewicht: 1284g
- ISBN-13: 9780367705640
- ISBN-10: 0367705648
- Artikelnr.: 62227702
- Verlag: Taylor & Francis Ltd (Sales)
- Seitenzahl: 568
- Erscheinungstermin: 1. März 2022
- Englisch
- Abmessung: 254mm x 178mm x 33mm
- Gewicht: 1284g
- ISBN-13: 9780367705640
- ISBN-10: 0367705648
- Artikelnr.: 62227702
Sarfaraz K. Niazi, Ph.D., is an Adjunct Professor at the University of Illinois and University of Houston; he has authored 60+ major books, 100+ research papers, and 100+ patents, mainly in the field of bioprocessing, drug discovery, mRNA vaccines, drug formulations, thermodynamic systems, alcohol aging, nutraceuticals and treatment of autoimmune diseases. He has established multiple biotechnology projects, from concept to market. He also serves as an advisor to major pharmaceutical and biopharmaceutical companies, regulatory agencies, the FDA, the US Congress, and several heads of state. He is also a patent law practitioner.
Preface.....................................................................................................................................................xix
Acknowledgments.................................................................................................................................xxvii
Author....................................................................................................................................................xxix
Glossary of Important
Terminology......................................................................................................xxxi
1 Understanding
Nonlinearity............................................................................................................
1
2 The Evolution of
Pharmaceuticals.................................................................................................
23
3 Artificial
Intelligence......................................................................................................................
69
4 Drug Discovery
Trends...................................................................................................................
91
5 Drug Development
Assays.............................................................................................................143
6
Nanomedicine................................................................................................................................
195
7
Antimicrobials................................................................................................................................231
8 Therapeutic
Proteins......................................................................................................................251
9 Manufacturing
Trends.................................................................................................................
307
10 Therapeutic Protein Delivery
Systems........................................................................................
345
11 Gene and Cell
Therapy..................................................................................................................381
12 Nucleic Acid
Vaccines....................................................................................................................421
13 Botanical
Products........................................................................................................................
439
14 Regulatory
Optimization..............................................................................................................
469
15 Intellectual
Property......................................................................................................................531
Index........................................................................................................................................................557
Acknowledgments.................................................................................................................................xxvii
Author....................................................................................................................................................xxix
Glossary of Important
Terminology......................................................................................................xxxi
1 Understanding
Nonlinearity............................................................................................................
1
2 The Evolution of
Pharmaceuticals.................................................................................................
23
3 Artificial
Intelligence......................................................................................................................
69
4 Drug Discovery
Trends...................................................................................................................
91
5 Drug Development
Assays.............................................................................................................143
6
Nanomedicine................................................................................................................................
195
7
Antimicrobials................................................................................................................................231
8 Therapeutic
Proteins......................................................................................................................251
9 Manufacturing
Trends.................................................................................................................
307
10 Therapeutic Protein Delivery
Systems........................................................................................
345
11 Gene and Cell
Therapy..................................................................................................................381
12 Nucleic Acid
Vaccines....................................................................................................................421
13 Botanical
Products........................................................................................................................
439
14 Regulatory
Optimization..............................................................................................................
469
15 Intellectual
Property......................................................................................................................531
Index........................................................................................................................................................557
Preface.....................................................................................................................................................xix
Acknowledgments.................................................................................................................................xxvii
Author....................................................................................................................................................xxix
Glossary of Important
Terminology......................................................................................................xxxi
1 Understanding
Nonlinearity............................................................................................................
1
2 The Evolution of
Pharmaceuticals.................................................................................................
23
3 Artificial
Intelligence......................................................................................................................
69
4 Drug Discovery
Trends...................................................................................................................
91
5 Drug Development
Assays.............................................................................................................143
6
Nanomedicine................................................................................................................................
195
7
Antimicrobials................................................................................................................................231
8 Therapeutic
Proteins......................................................................................................................251
9 Manufacturing
Trends.................................................................................................................
307
10 Therapeutic Protein Delivery
Systems........................................................................................
345
11 Gene and Cell
Therapy..................................................................................................................381
12 Nucleic Acid
Vaccines....................................................................................................................421
13 Botanical
Products........................................................................................................................
439
14 Regulatory
Optimization..............................................................................................................
469
15 Intellectual
Property......................................................................................................................531
Index........................................................................................................................................................557
Acknowledgments.................................................................................................................................xxvii
Author....................................................................................................................................................xxix
Glossary of Important
Terminology......................................................................................................xxxi
1 Understanding
Nonlinearity............................................................................................................
1
2 The Evolution of
Pharmaceuticals.................................................................................................
23
3 Artificial
Intelligence......................................................................................................................
69
4 Drug Discovery
Trends...................................................................................................................
91
5 Drug Development
Assays.............................................................................................................143
6
Nanomedicine................................................................................................................................
195
7
Antimicrobials................................................................................................................................231
8 Therapeutic
Proteins......................................................................................................................251
9 Manufacturing
Trends.................................................................................................................
307
10 Therapeutic Protein Delivery
Systems........................................................................................
345
11 Gene and Cell
Therapy..................................................................................................................381
12 Nucleic Acid
Vaccines....................................................................................................................421
13 Botanical
Products........................................................................................................................
439
14 Regulatory
Optimization..............................................................................................................
469
15 Intellectual
Property......................................................................................................................531
Index........................................................................................................................................................557